Previous 10 | Next 10 |
home / stock / dose:cc / dose:cc news
Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), has filed its financial results for the first three quarters of the 2023 fiscal year. Now that the Company has completed the filing of its audited financial statements for the fiscal year ended Feb...
On Friday, January 27, 2023, Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), filed its financial results for the fiscal year ended February 28, 2022. Now that the Company has completed the filing of its audited financial statements for the fisca...
Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company revolutionizing drug delivery through innovation, is one of five Canadian companies accepted into this year’s Venture Mentoring Servi...
Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company focused on health and wellness leveraging an innovative, proprietary oral delivery platform today announced that they have entered i...
Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated August 29, 2022, the Company and its aud...
Rapid Dose Therapeutics Corp. (“ RDT ” or the “ Company ”) ( CSE: DOSE ), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced that it has closed on $230,000 in a first tranche of its previously announ...
Rapid Dose Therapeutics Corp. ( “RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is providing a bi-weekly default status update in accordance with National Policy 12-203 – Management Cea...
Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that, further to its press release dated June 16, 2022 (the “Default Announcement”), at th...
Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, announces that it will not be in a position to file its audited annual financial statements for the fiscal year en...
Rapid Dose Therapeutics Corp. (“ RDT” ), ( CSE: DOSE) , a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, today announced that it plans to complete a private placement financing (the “ Financing ”) for ...
News, Short Squeeze, Breakout and More Instantly...
Rapid Dose Therapeutics Corp. Company Name:
DOSE:CC Stock Symbol:
CNQC Market:
Rapid Dose Therapeutics Corp. Website:
Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") is pleased to announce that it has closed a first tranche of its previously announced equity private placement financing (the " Financing ") for aggregate gross proceeds ...
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company ") announced today that as contemplated in the secured convertible notes (the " Notes ") previously issued on its private placement financing (the " Financing "), the Company...
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (" RDT " or the " Company "), is pleased to announce the filing of its financial results for the year ended February 29, 2024. Mark Upsdell, Chairman and Chief Executive Officer, stated, "Over ...